IBI302

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for IBI302, covering 2024-11-18 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD [Phase 2]